Trillium Asset Management LLC Has $785,000 Position in Waters Co. (NYSE:WAT)

Trillium Asset Management LLC cut its position in shares of Waters Co. (NYSE:WAT) by 2.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,116 shares of the medical instruments supplier’s stock after selling 51 shares during the period. Trillium Asset Management LLC’s holdings in Waters were worth $785,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of WAT. Bank of Jackson Hole Trust acquired a new position in Waters during the fourth quarter worth approximately $34,000. Fortitude Family Office LLC boosted its stake in shares of Waters by 235.7% during the 4th quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier’s stock worth $35,000 after acquiring an additional 66 shares during the period. Steward Partners Investment Advisory LLC increased its holdings in shares of Waters by 129.3% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 94 shares of the medical instruments supplier’s stock worth $35,000 after acquiring an additional 53 shares during the last quarter. EverSource Wealth Advisors LLC increased its holdings in shares of Waters by 54.3% during the 4th quarter. EverSource Wealth Advisors LLC now owns 125 shares of the medical instruments supplier’s stock worth $46,000 after acquiring an additional 44 shares during the last quarter. Finally, R Squared Ltd acquired a new stake in Waters during the 4th quarter valued at $63,000. 94.01% of the stock is owned by institutional investors.

Waters Trading Down 2.8 %

WAT opened at $371.61 on Thursday. The company has a quick ratio of 0.65, a current ratio of 0.94 and a debt-to-equity ratio of 1.14. Waters Co. has a twelve month low of $279.24 and a twelve month high of $423.56. The stock has a market capitalization of $22.08 billion, a price-to-earnings ratio of 34.70, a P/E/G ratio of 3.79 and a beta of 1.00. The company has a 50-day simple moving average of $391.31 and a 200 day simple moving average of $370.98.

Waters (NYSE:WAT) last posted its quarterly earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.02 by $0.08. Waters had a net margin of 21.56% and a return on equity of 46.31%. Analysts predict that Waters Co. will post 12.86 EPS for the current fiscal year.

Analysts Set New Price Targets

WAT has been the topic of several research reports. Bank of America decreased their price objective on shares of Waters from $430.00 to $410.00 and set a “neutral” rating on the stock in a report on Thursday, February 13th. Sanford C. Bernstein raised shares of Waters from a “market perform” rating to an “outperform” rating and set a $430.00 price target on the stock in a report on Friday, January 10th. Barclays upgraded shares of Waters from an “underweight” rating to an “equal weight” rating and raised their price objective for the stock from $360.00 to $415.00 in a research report on Monday, February 10th. UBS Group upped their target price on Waters from $405.00 to $410.00 and gave the company a “neutral” rating in a research report on Thursday, February 13th. Finally, StockNews.com cut Waters from a “buy” rating to a “hold” rating in a report on Tuesday, February 25th. Eleven equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $391.07.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.